CWF19L1

CWF19L1 (hDrn1) is a nuclear-cytoplasmic shuttling protein that participates in pre-mRNA splicing through physical association with the spliceosomal machinery (PMID:25671812, PMID:39542248). It directly binds the lariat RNA debranching enzyme hDbr1 and mirrors its nucleocytoplasmic distribution (PMID:25671812), and within the nucleus it interacts with components of the U5 small nuclear ribonucleoprotein and the PRPF19 complex to function as a splicing regulator (PMID:39542248). Loss of CWF19L1 disrupts alternative splicing of immune-related genes, lowering expression of cytotoxic molecules and effector cytokines and impairing T cell-mediated antitumor cytotoxicity (PMID:39542248). CWF19L1 is required for normal cerebellar development and motor function, as a homozygous splice-site mutation causing exon skipping and protein loss produces a cerebellar phenotype in patients and zebrafish knockdown alters cerebellar morphology with movement abnormalities (PMID:25361784). In glioma cells its expression is controlled by H3K27ac at the promoter, and elevated CWF19L1 drives degradation of CDK4/6 and G1 cell cycle arrest (PMID:32508030).

1. 2014 Medium

   Establishing whether CWF19L1 has an essential physiological role, a defined loss-of-function model linked the gene to cerebellar development and a human disease phenotype.

   Evidence Morpholino knockdown in zebrafish with cerebellar/motor readouts plus RT-PCR and immunoblotting confirmation of a patient splice-site mutation

   PMID:25361784

   Open questions at the time

   • Molecular mechanism linking CWF19L1 loss to cerebellar defects not defined
   • No demonstration of which splicing or RNA targets underlie the neurological phenotype
2. 2015 Medium

   To place CWF19L1 in a biochemical pathway, it was shown to directly bind the lariat debranching enzyme hDbr1 and to shuttle between nucleus and cytoplasm, implicating it in RNA lariat/intron metabolism.

   Evidence Co-IP with mass spectrometry, direct interaction assay, and subcellular localization in human cells

   PMID:25671812

   Open questions at the time

   • Functional consequence of the hDrn1-hDbr1 interaction on debranching not established
   • Single-lab interaction without genetic epistasis
3. 2019 Low

   Addressing post-transcriptional control of the gene itself, 3'UTR RNA editing was found to raise CWF19L1 protein levels and alter cell proliferation.

   Evidence Computational identification of editing sites with protein-level validation and proliferation assays in HEK cells

   PMID:31162949

   Open questions at the time

   • Single experiment per finding with mechanistic details not described
   • No link between editing-driven expression changes and a defined molecular pathway
4. 2020 Medium

   Connecting CWF19L1 to cell cycle control, its promoter was shown to be regulated by H3K27ac and its upregulation to trigger CDK4/6 degradation and G1 arrest in glioma.

   Evidence ChIP-qPCR for promoter regulation, mass spectrometry, and in vitro/in vivo cell cycle analysis

   PMID:32508030

   Open questions at the time

   • Mechanism by which CWF19L1 promotes CDK4/6 degradation unknown
   • Relationship between cell-cycle role and splicing function not integrated
5. 2024 Medium

   Defining the core molecular activity, CWF19L1 was shown to act as a splicing regulator interacting with U5 snRNP and PRPF19 complex components, with loss disrupting immune-gene splicing and antitumor T cell cytotoxicity.

   Evidence Co-IP with splicing factors, alternative splicing analysis, and loss-of-function with cytotoxicity and gene-expression readouts

   PMID:39542248

   Open questions at the time

   • Direct versus indirect nature of spliceosome association not resolved
   • Specific splice targets driving the cytotoxicity defect not fully mapped
   • Single-lab evidence
6. 2025 Low

   Refining nuclear organization, super-resolution imaging placed CWF19L1 in a distinct but closely associated nuclear pattern relative to its paralog CWF19L2.

   Evidence Super-resolution immunofluorescence imaging

   PMID:41422678

   Open questions at the time

   • CWF19L1 localization was incidental to a CWF19L2-focused study
   • No functional consequence tied to CWF19L1 from this observation

• How the splicing/debranching activity, the CDK4/6-degrading cell-cycle role, and the cerebellar developmental requirement of CWF19L1 mechanistically connect into a single pathway remains unresolved.
• No unifying biochemical mechanism linking splicing function to cell-cycle and developmental phenotypes
• No structural model of CWF19L1 or its spliceosome contacts
• Direct catalytic activity, if any, undefined